Chemistry & Biology
Volume 13, Issue 1, January 2006, Pages 23-30
Journal home page for Chemistry & Biology

Article
Peroxisome Proliferator-Activated Receptor α Antagonism Inhibits Hepatitis C Virus Replication

https://doi.org/10.1016/j.chembiol.2005.10.006Get rights and content
Under an Elsevier user license
open archive

Summary

Hepatitis C virus (HCV) is a global health problem and a leading cause of liver disease. Here, we demonstrate that the replication of HCV replicon RNA in Huh-7 cells is inhibited by a peroxisome proliferator-activated receptor (PPAR) antagonist, 2-chloro-5-nitro-N-(pyridyl)benzamide (BA). Downregulation of PPARγ with RNA interference approaches had no effect on HCV replication in Huh-7 cells, whereas PPARα downregulation inhibited HCV replication. Fluorescence and coherent anti-Stokes Raman scattering (CARS) microscopy demonstrate a clear buildup of lipids upon treatment with BA. These observations are consistent with the misregulation of lipid metabolism, phospholipid secretion, cholesterol catabolism, and triglyceride clearance events associated with the inhibition of PPARα. The inhibition of HCV replication by BA may result from disrupting lipidation of host proteins associated with the HCV replication complex or, more generally, by disrupting the membranous web where HCV replicates.

Cited by (0)